Quick Search 
Drugs of the Future
Register or sign in

Volume 30, Issue 9, September 2005, Pages 873-980
Treatment of transplant rejection.
McIntyre, J.A., Fernandez, D.
Drugs Fut 2005, 30(9): 873
Summary | Full Text: HTMLPDF 
 Dabigatran/Dabigatran Etexilate.
Prevention of deep venous thrombosis, Prevention of ischemic stroke, Thrombin inhibitor.
Sorbera, L.A., Bozzo, J., Castaner, J.
Drugs Fut 2005, 30(9): 877
Summary | Full Text: HTMLPDF 
Anti-hepatitis C virus drug, TLR7 receptor agonist.
Davies, S.L., Castaner, J., Fernandez, D.
Drugs Fut 2005, 30(9): 886
Summary | Full Text: HTMLPDF 
Prostate cancer therapy.
McIntyre, J.A., Fernandez, D.
Drugs Fut 2005, 30(9): 892
Summary | Full Text: HTMLPDF 
 A new cancer immunosuppression target: indoleamine 2,3-dioxygenase (IDO). A review of the IDO mechanism, inhibition and therapeutic applications.
Malachowski, W.P., Metz, R., Prendergast, G.C., Muller, A.J.
Drugs Fut 2005, 30(9): 897
Summary | Full Text: HTMLPDF 
 Cyclin-dependent kinase inhibitors: discovery, development and target rationale for different therapeutic applications.
Fischer, P.M.
Drugs Fut 2005, 30(9): 911
Summary | Full Text: HTMLPDF 
Annual Update 2004/2005
 Treatment of Genitourinary Disorders.
N.E. Mealy, M. Bayés
Drugs Fut 2005, 30(9): 931
Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy